Polymeric microneedle pretreatment transformed GHK-Cu skin delivery from essentially zero permeation through intact skin to 134 nanomoles of peptide in 9 hours through human skin — safely and without irritation.
From zero to 134 nanomoles of peptide through skinIntact human skin blocks virtually all GHK-Cu absorption, but microneedle pretreatment enabled substantial peptide delivery in just 9 hours
What the researchers found
Microneedle pretreatment of human skin enabled dramatic GHK-Cu permeation: 134 ± 12 nanomoles of peptide and 705 ± 84 nanomoles of copper crossed the skin in 9 hours, versus essentially zero through intact skin. The depth and percentage of microneedle penetration were directly correlated with application force, which determined the degree of permeability enhancement. Histological assays and confocal microscopy confirmed well-defined channels through the stratum corneum. No skin irritation was observed.
Why it matters
GHK-Cu is one of the most well-studied regenerative peptides with demonstrated abilities to stimulate collagen synthesis and accelerate wound healing. However, topical application has been limited by near-zero skin absorption. Microneedle patches offer a practical, painless solution that creates only temporary microchannels healing within hours. This could finally make GHK-Cu an effective topical therapy.
How the study worked
Polymeric microneedle arrays were used to pretreat skin samples before GHK-Cu application. Two in vitro skin permeation models (including human skin) assessed drug delivery. Histological examination and confocal laser scanning microscopy characterized microconduits. Application force was varied to establish force-penetration-permeation relationships. Safety was assessed using keratinocyte cell viability assays and porcine skin irritation models.
What this study cannot tell us
The study used in vitro skin models — actual in vivo absorption may differ due to blood flow and metabolism. The 9-hour permeation window may not reflect practical use patterns. Long-term safety of repeated microneedle use was not assessed. The biological activity of delivered GHK-Cu was not measured, only the quantity that permeated. Clinical efficacy was not tested.
How to read the evidence
This is a well-designed in vitro skin permeation study using human skin models with appropriate controls and safety characterization. The permeation data is robust but clinical testing is absent.
When this study was published
Published in 2015, this is about a decade old. Microneedle technology has advanced significantly since, with dissolvable patches now in clinical development for various applications.
The bigger picture
Microneedle technology has exploded in recent years with applications from vaccine delivery to insulin administration. This study applies it to cosmeceutical peptide delivery. The demonstration that microneedles can deliver both the peptide and its copper cofactor simultaneously is particularly practical, as GHK-Cu's activity requires the intact peptide-metal complex. The approach is generalizable to other hydrophilic peptides facing the same skin penetration barrier.
Questions still open
- Does the GHK-Cu delivered via microneedles retain full biological activity and produce measurable skin regeneration in vivo?
- Could dissolvable microneedle patches pre-loaded with GHK-Cu provide a more convenient single-step application?
- What is the optimal microneedle application frequency for chronic anti-aging use?
Common questions
Why can't copper peptide products just be rubbed onto the skin?
Are microneedle patches safe to use at home for peptide delivery?
Read the original research
Microneedle-Mediated Delivery of Copper Peptide Through Skin.
Pharmaceutical research, 32(8), 2678-89
Citation
Li, Hairui; Low, Yong Sheng Jason; Chong, Hui Ping; Zin, Melvin T; Lee, Chi-Ying; Li, Bo; Leolukman, Melvina; Kang, Lifeng. (2015). Microneedle-Mediated Delivery of Copper Peptide Through Skin.. Pharmaceutical research, 32(8), 2678-89. https://doi.org/10.1007/s11095-015-1652-z